Jagsonpal Pharmaceuticals Ownership
JAGSNPHARM | 636.65 9.80 1.52% |
Shares in Circulation | First Issued 2011-09-30 | Previous Quarter 27.6 M | Current Value 27 M | Avarage Shares Outstanding 26.3 M | Quarterly Volatility 298.1 K |
Please note, institutional investors have a lot of resources and new technology at their disposal. They can put in a lot of research and financial analysis when reviewing investment options. There are many different types of institutional investors, including banks, hedge funds, insurance companies, and pension plans. One of the main advantages they have over retail investors is the fees paid for trades. As they are buying in large quantities, they can manage their cost more effectively.
Jagsonpal |
Jagsonpal Stock Ownership Analysis
About 76.0% of the company shares are held by company insiders. The company recorded earning per share (EPS) of 8.99. Jagsonpal Pharmaceuticals last dividend was issued on the 6th of September 2024. The entity had 2.5:1 split on the 8th of January 2025. To learn more about Jagsonpal Pharmaceuticals Limited call the company at 91 12 4440 6710 or check out https://www.jagsonpal.com.Jagsonpal Pharmaceuticals Outstanding Bonds
Jagsonpal Pharmaceuticals issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Jagsonpal Pharmaceuticals uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Jagsonpal bonds can be classified according to their maturity, which is the date when Jagsonpal Pharmaceuticals Limited has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
Dana 575 percent Corp BondUS235822AB96 | View | |
Volcan Compania Minera Corp BondUSP98047AC08 | View | |
Boeing Co 2196 Corp BondUS097023DG73 | View | |
HSBC Holdings PLC Corp BondUS404280DR76 | View | |
MPLX LP 4875 Corp BondUS55336VAG59 | View | |
MPLX LP 4125 Corp BondUS55336VAK61 | View | |
MPLX LP 52 Corp BondUS55336VAL45 | View | |
International Game Technology Corp BondUS460599AD57 | View |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Other Information on Investing in Jagsonpal Stock
Jagsonpal Pharmaceuticals financial ratios help investors to determine whether Jagsonpal Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Jagsonpal with respect to the benefits of owning Jagsonpal Pharmaceuticals security.